Randomized, Open-Label Study of the BRIA-IMT Regimen and Check Point Inhibitor vs Physician's Choice in Advanced Metastatic Breast Cancer (BRIA-ABC)

Activity Type
Clinical Trial
Date
Dollar Amount
*
Grant Type
Contract
Principal Investigator
Sima Ehsani Chimeh
Sponsor
BriaCell Therapeutics Corp
Unit
Cancer Center Division